Sabby Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Sabby Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,431	Closed	-$177K	–	223
2021 Q3	$241K	Sell	70,431 -371,042	-84%	-$1.14M	0.03%	138
2021 Q2	$1.32M	Sell	441,473 -88,527	-17%	-$280K	0.19%	74
2021 Q1	$1.71M	Buy	+530,000	New	+$1.77M	0.33%	58
2016 Q3	–	Sell	-22,500	Closed	-$34.6K	–	345
2016 Q2	$30K	Buy	+22,500	New	+$105K	﹤0.01%	281
2015 Q4	–	Sell	-30,000	Closed	-$258K	–	379
2015 Q3	$254K	Buy	+30,000	New	+$277K	0.01%	337
2014 Q4	–	Sell	-5,438	Closed	-$79.2K	–	293
2014 Q3	$73	Buy	+5,438	New	+$64.8K	﹤0.01%	238
2014 Q1	–	Sell	-70,000	Closed	-$967K	–	280
2013 Q4	$967K	Buy	+70,000	New	+$989K	0.06%	123
2013 Q3	–	Sell	-29,188	Closed	-$559K	–	240
2013 Q2	$474K	Buy	+29,188	New	+$903K	0.03%	145

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sabby Management's INFI Position: Q4 2021 in Review

Sabby Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 70,431 shares — an estimated $177K sold.

Sabby Management first reported a position in INFI in Q2 2013 and held it in 8 quarters. The position peaked at $1.71M in Q1 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

Sabby Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Sabby Management sold 70,431 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $177K.
Sabby Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Sabby Management's Infinity Pharmaceuticals, Inc. position peaked at $1.71M in Q1 2021.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.